30.87 USD
↗ 0.39 (1.28%)AT CLOSE (03:59 PM EST)
Viridian Therapeutics, Inc. Common Stock (VRDN) trades at $30.87 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a weak Piotroski F-Score of 1/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, VRDN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 13, 2026.